Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
Open Access
- 30 April 2004
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 40 (4), 669-674
- https://doi.org/10.1016/j.jhep.2003.12.015
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Natural history of recurrent hepatitis CLiver Transplantation, 2002
- Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis CGut, 2002
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- Recurrence of hepatitis C after liver transplantation: follow-up and treatmentTransplantation Proceedings, 2002
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CGastroenterology, 2002
- IMPACT OF THE RECURRENCE OF HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION ON THE LONG-TERM VIABILITY OF THE GRAFT1Transplantation, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantationHepatology, 1997
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationThe New England Journal of Medicine, 1996